Puma Biotechnology Inc (PBYI) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Puma Biotechnology Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.153 Good afternoon, my name is Darrell and I will be your conference call operator today. 00:00:05.153 -- 00:00:08.874 At this time, all participants are in a listen-only mode. 00:00:08.874 -- 00:00:12.895 After the speaker's formal remarks, there will be a question and answer session. 00:00:12.895 -- 00:00:16.516 If you would like to ask a question during that time, simply press the star key, then 00:00:16.516 -- 00:00:20.918 the number 1 on your telephone keypad. If you would like to withdraw your questions, 00:00:20.918 -- 00:00:25.760 please press star 2. If you should require operator assistance during the conference, 00:00:25.760 -- 00:00:28.185 please press star 0. 00:00:28.185 -- 00:00:31.328 As a reminder, this call is being recorded. 00:00:31.328 -- 00:00:35.391 I would now like to turn the conference call over to Mariann Ohanesian, Senior Director 00:00:35.391 -- 00:00:37.733 of IR for PUMA Biotechnology. 00:00:37.733 -- 00:00:40.354 You may begin your conference. 00:00:40.415 -- 00:00:44.979 Thank you, Darrell. Good afternoon and welcome to PUMA's conference call to discuss our 00:00:44.979 -- 00:00:48.863 earnings results for the second quarter of 2026. 00:00:48.863 -- 00:00:53.967 Joining me on the call today are Alan Auerbach, Chief Executive Officer, President and 00:00:53.967 -- 00:00:56.723 Chairman of the Board of PUMA Biotechnology, 00:00:56.723 -- 00:01:02.044 Maximo Nougues, Chief Financial Officer, Heather Blaber, Senior Vice President 00:01:02.044 -- 00:01:06.805 of Marketing, and Roger Storms, Senior Vice President of Sales. 00:01:06.805 -- 00:01:11.386 After the close today, PUMA issued a news release detailing earnings results for the 00:01:11.386 -- 00:01:14.046 second quarter of 2026. That 00:01:14.046 -- 0...